What is Trulicity®?

Posted on July 17, 2023 by Sally-Anne Turner

Obesity and weight loss struggles impact millions of people worldwide, creating a complex web of health challenges that extend far beyond the number on the scales. The physical, emotional, and psychological toll of carrying excess weight affects every aspect of daily life, from mobility and energy levels to self-confidence and social interactions. For many people, obesity isn't simply about eating too much or exercising too little—it's a multifaceted medical condition influenced by genetics, hormones, metabolism, environment, and underlying health issues that make weight management extraordinarily difficult without proper medical support.

The health implications of obesity are serious and far-reaching. Excess weight significantly increases the risk of developing type 2 diabetes, a chronic condition characterised by high blood sugar levels due to insulin resistance or insufficient insulin production. When your body becomes resistant to insulin or cannot produce enough of this vital hormone, glucose accumulates in your bloodstream rather than being absorbed by your cells for energy. This persistent elevation in blood sugar can damage blood vessels, nerves, and organs throughout your body over time.

Uncontrolled diabetes can lead to serious health complications that dramatically impact quality of life and longevity, such as heart disease, stroke, kidney failure, and blindness. Beyond diabetes, obesity is strongly associated with cardiovascular disease, high blood pressure, certain cancers, sleep apnoea, fatty liver disease, osteoarthritis, and mental health challenges including depression and anxiety. The cumulative effect of these conditions places enormous strain on the NHS, with obesity-related illnesses costing billions of pounds annually in treatment and lost productivity.

Fortunately, there are several effective treatments available for managing obesity and type 2 diabetes, including lifestyle changes, oral medications, and injectable therapies. The landscape of medical weight loss has evolved dramatically in recent years, with new understanding of the biological mechanisms underlying obesity leading to innovative pharmaceutical interventions that work with your body's natural systems rather than against them. These treatments don't replace healthy eating and physical activity, but they provide crucial support that makes sustainable weight loss achievable for people who have struggled for years with traditional diet and exercise approaches alone.

One such injectable therapy that has shown considerable promise in clinical settings is Trulicity, a medication that addresses both diabetes management and weight loss through a sophisticated mechanism that mimics your body's own regulatory systems.

Trulicity® is a medication that was created by an American pharmaceutical company, Eli-Lilly and Company, specifically to treat type 2 diabetes, but it can be prescribed as a medical aid for weight loss when used as part of a comprehensive, clinically supervised programme. Eli Lilly has a long history of developing groundbreaking diabetes treatments, and Trulicity represents one of their most significant contributions to metabolic health management. The medication received regulatory approval from the FDA in the United States in 2014 and has since been approved in numerous countries worldwide, including the United Kingdom, where it is available through both NHS and private prescription pathways.

It belongs to a class of drugs called GLP-1 receptor agonists, a category of medications that has revolutionised the treatment of type 2 diabetes and obesity over the past fifteen years. These drugs work by mimicking the effects of a natural hormone called glucagon-like peptide-1 (GLP-1) in the body, essentially amplifying a signal that your body already produces but may not be producing in sufficient quantities or responding to effectively. GLP-1 is secreted by specialised cells in the intestine in response to food intake and stimulates the release of insulin from the pancreas, which helps to lower blood sugar levels by enabling glucose to enter your cells where it can be used for energy rather than accumulating in your bloodstream.

The discovery of GLP-1 and its potential therapeutic applications represents a major breakthrough in understanding how the gut and brain communicate to regulate appetite, blood sugar, and metabolism. Unlike older diabetes medications that simply force the pancreas to produce more insulin regardless of blood sugar levels—which can lead to dangerous episodes of hypoglycaemia—GLP-1 receptor agonists work in a glucose-dependent manner, meaning they only stimulate insulin release when blood sugar is elevated. This intelligent mechanism significantly reduces the risk of low blood sugar events whilst still providing effective glycaemic control.

How does Trulicity® work?

Trulicity® is a once-weekly injection that contains the active ingredient dulaglutide, a synthetic analogue of human GLP-1 that has been engineered to remain active in the body for an extended period. The once-weekly dosing schedule represents a significant advantage over some earlier GLP-1 medications that required daily injections, making treatment more convenient and improving adherence. The medication comes in a pre-filled pen device that is designed for ease of use, with a hidden needle and simple push-button mechanism that makes self-administration straightforward even for people who are needle-phobic or have never given themselves an injection before.

Like other GLP-1 receptor agonists, Trulicity® works by stimulating the body's natural production of insulin secretion when blood glucose levels are elevated. When you inject Trulicity, the dulaglutide molecules bind to GLP-1 receptors on the surface of beta cells in your pancreas, triggering a cascade of cellular events that result in the release of insulin. This insulin then facilitates the movement of glucose from your bloodstream into your muscle, liver, and fat cells where it can be stored or used for energy, thereby lowering your blood sugar levels naturally and safely.

It also inhibits the release of glucagon, a hormone produced by the pancreas that has the opposite effect of insulin—it signals your liver to release stored glucose into your bloodstream. In people with type 2 diabetes, glucagon levels are often inappropriately elevated, contributing to high blood sugar even during fasting periods. By suppressing glucagon secretion, Trulicity helps prevent your liver from dumping excess glucose into your blood when it's not needed, providing better overall glycaemic control throughout the day and night.

Additionally, Trulicity slows digestion by delaying gastric emptying—the rate at which food moves from your stomach into your small intestine. This has multiple beneficial effects: it helps prevent the rapid spikes in blood sugar that occur after meals, it prolongs the feeling of fullness and satisfaction after eating, and it reduces the frequency and intensity of hunger signals between meals, all of which contribute significantly to weight loss.

This is because Trulicity® increases satiety and reduces appetite, leading to a reduction in calorie intake to aid weight loss. The appetite-suppressing effects of Trulicity are not simply about willpower or forcing yourself to eat less—they work at a fundamental biological level to change how your brain perceives hunger and fullness. It works by mimicking the natural hormones that your body produces, signalling to the brain and gastrointestinal systems that food has been consumed and that nutritional needs have been met.

This results in a complex cascade of hormones and neurotransmitters which effectively communicate feelings of fullness and slow down the rate at which food leaves your stomach, making users feel fuller for longer periods after eating. The medication essentially helps restore normal appetite regulation in people whose hunger signals have become dysregulated due to insulin resistance, metabolic syndrome, or other factors associated with obesity. Many patients report that the constant food thoughts, cravings, and preoccupation with eating that previously dominated their days simply diminish or disappear whilst taking Trulicity, making it much easier to follow a healthy eating plan and maintain a calorie deficit necessary for weight loss.

The weight loss effects of Trulicity can be substantial when combined with appropriate dietary modifications and increased physical activity. Clinical studies have demonstrated that patients taking Trulicity typically lose more weight than those on placebo or some other diabetes medications, with the degree of weight loss varying based on individual factors such as starting weight, adherence to lifestyle changes, dosage, and duration of treatment. For people struggling with both obesity and type 2 diabetes, this dual benefit—improved blood sugar control and weight reduction—makes Trulicity an particularly attractive treatment option.

At Bodyline Clinic, we have extensive experience prescribing and monitoring GLP-1 medications as part of comprehensive, medically supervised weight loss programmes. Our specialist clinical team understands that medications like Trulicity are most effective when integrated into a holistic treatment plan that addresses nutrition, physical activity, behavioural patterns, and ongoing support. We don't simply prescribe medication and send you on your way—we provide the guidance, monitoring, and encouragement you need to achieve sustainable results and maintain your weight loss long-term.

Contact Bodyline today to find out more about our safe and effective weight loss programmes and range of treatment options.

Is Trulicity® the same as Ozempic?

Trulicity® and Ozempic are both medications used to aid in weight loss alongside diet and exercise, and whilst they share many similarities, they are not identical medications. This is a common question we receive at Bodyline Clinic, as patients naturally want to understand the differences between available treatment options to make informed decisions about their care. Both medications have received significant media attention in recent years due to their effectiveness for weight loss, leading to increased public awareness and interest in GLP-1 therapies.

They both contain a GLP-1 receptor agonist, which mimics the effects of a natural hormone called glucagon-like peptide-1 (GLP-1) in the body, working through the same fundamental mechanism to improve blood sugar control and promote weight loss. Both medications are administered as subcutaneous injections, meaning they are injected into the fatty tissue just beneath the skin, typically in the abdomen, thigh, or upper arm. Both are designed for once-weekly dosing, which represents a significant convenience advantage over older diabetes medications that required multiple daily doses.

However, there are important distinctions between these two medications that may make one more suitable than the other for certain patients. Trulicity® is a once-weekly injection that contains dulaglutide as its active ingredient, whilst Ozempic is also a once-weekly injection that contains semaglutide as its active ingredient. These are different molecular compounds, though they work through similar mechanisms. The chemical structure of semaglutide allows it to remain in the body slightly longer than dulaglutide, which may contribute to differences in efficacy and side effect profiles between the two medications.

Studies have shown that both Trulicity® and Ozempic are effective in reducing blood sugar levels over time and promoting weight loss in people with type 2 diabetes and obesity. Clinical trials have demonstrated that both medications significantly improve HbA1c levels (a measure of average blood sugar control over the previous three months) and lead to meaningful weight reduction when used as part of a comprehensive diabetes management or weight loss programme. However, head-to-head comparison studies have suggested that semaglutide (Ozempic) may produce slightly greater weight loss and HbA1c reduction compared to dulaglutide (Trulicity) at their respective maximum doses, though individual responses vary considerably.

The side effect profiles of the two medications are broadly similar, as both work through the same GLP-1 mechanism, but there may be subtle differences in the frequency and severity of gastrointestinal side effects such as nausea, vomiting, diarrhoea, and constipation. Some patients tolerate one medication better than the other, and if side effects become problematic with one GLP-1 agonist, switching to a different one within the same class may be beneficial. At Bodyline, our experienced clinicians can help you navigate these choices based on your individual medical history, treatment goals, and response to therapy.

It's also worth noting that whilst Ozempic has become widely known for weight loss, it is officially approved only for type 2 diabetes treatment in the UK. The same active ingredient (semaglutide) is available in a higher-dose formulation specifically for weight loss under the brand name Wegovy. Trulicity, similarly, is primarily approved for diabetes treatment but may be prescribed off-label for weight loss by qualified clinicians when clinically appropriate. The regulatory landscape around these medications continues to evolve as more evidence accumulates regarding their safety and effectiveness for various indications.

Another practical consideration is cost and availability. The pricing of these medications can vary, and availability may be affected by supply chain issues or prescribing restrictions. At Bodyline, we work with multiple pharmaceutical suppliers to ensure our patients have access to the most appropriate medication for their needs, whether that's Trulicity, Ozempic, Wegovy, Mounjaro, or other options within our treatment portfolio. Our clinical team stays informed about the latest research and can advise you on which medication is likely to be most effective and cost-efficient for your particular situation.

Benefits of Trulicity®

One of the benefits of Trulicity® is that it is relatively easy to use compared to many other injectable medications. It is available as a once-weekly injection, which can be administered at home without requiring visits to a clinic or medical professional for each dose. This convenience factor is significant for busy individuals who may struggle to remember daily medications or who travel frequently for work or leisure. The once-weekly schedule also means fewer injections overall, which many patients find psychologically easier to manage than daily injections.

The Trulicity pen device itself has been designed with patient comfort and ease of use in mind. Unlike traditional syringes that require you to draw up medication from a vial, measure the correct dose, and manually inject, the Trulicity pen comes pre-filled with the exact dose prescribed by your doctor. The pen features a hidden needle that you never have to see, which can be particularly reassuring for people with needle phobia. The injection is administered with a simple push of a button, and the entire process takes just seconds. The pen also has built-in safety features to prevent accidental needle sticks and ensure proper dosing.

This means that individuals taking Trulicity® can continue with their daily activities without any disruption to their normal routines. You can inject at any time of day that's convenient for you, with or without food, and the day of the week can be adjusted if needed (for example, if you forget a dose, you can take it as soon as you remember as long as your next scheduled dose is at least three days away). This flexibility makes it easier to integrate the medication into your lifestyle, whether you prefer to inject first thing in the morning, during your lunch break, or before bed.

Another important aspect of Trulicity® is that it has been shown to reduce the risk of major adverse cardiovascular events such as heart attack, stroke, and cardiovascular death in adults with type 2 diabetes who have established cardiovascular disease or multiple cardiovascular risk factors. This cardiovascular benefit was demonstrated in the REWIND trial, a large-scale clinical study that followed thousands of patients over several years. The trial showed that Trulicity reduced the risk of major adverse cardiovascular events by 12% compared to placebo, which is a clinically meaningful benefit that extends beyond blood sugar control and weight loss.

For people with type 2 diabetes, cardiovascular disease is the leading cause of death, so any medication that can reduce this risk whilst also improving glycaemic control and promoting weight loss represents a significant therapeutic advance. The cardiovascular benefits of Trulicity appear to be independent of its effects on blood sugar and weight, suggesting that GLP-1 receptor agonists may have direct protective effects on the heart and blood vessels. Proposed mechanisms include improvements in blood pressure, reduction in inflammation, beneficial effects on cholesterol levels, and direct actions on the heart muscle and blood vessel walls.

Additional benefits of Trulicity include its low risk of causing hypoglycaemia (dangerously low blood sugar) when used alone or in combination with metformin, which is the most commonly prescribed first-line medication for type 2 diabetes. Because Trulicity works in a glucose-dependent manner—only stimulating insulin release when blood sugar is elevated—it doesn't cause the problematic blood sugar crashes that can occur with some other diabetes medications, particularly sulfonylureas and insulin. This makes Trulicity a safer option for many patients, particularly those who drive, operate machinery, or engage in activities where hypoglycaemia could be dangerous.

Many patients also report improvements in energy levels, mood, and overall quality of life whilst taking Trulicity, likely related to the combined effects of better blood sugar control, weight loss, and reduced inflammation. When your blood sugar is better controlled, you avoid the energy crashes and fatigue associated with glucose fluctuations. As you lose weight, physical activities become easier and more enjoyable, mobility improves, and many obesity-related symptoms such as joint pain, sleep apnoea, and shortness of breath diminish or resolve entirely.

At Bodyline Clinic, we've observed these benefits firsthand in our patients who use Trulicity as part of their medically supervised weight loss programmes. Our experienced clinical team provides comprehensive support throughout your treatment journey, helping you maximise the benefits of your medication whilst minimising potential side effects through careful dose titration, nutritional guidance, and ongoing monitoring. We understand that successful weight loss isn't just about the medication—it's about the complete package of medical care, education, and support that empowers you to make lasting changes.

Is Trulicity right for you?

If you suffer from obesity, particularly if you also have type 2 diabetes or are at high risk of developing diabetes, it is important to speak with our qualified medical professionals to determine if Trulicity® is the right treatment option for you. Not everyone is a suitable candidate for GLP-1 medications, and a thorough medical assessment is essential to ensure safety and appropriateness. A specialist at Bodyline can help determine if Trulicity® is the right option for you based on your medical history, current medications, weight loss goals, and individual risk factors, and can monitor your progress to ensure that it is effective and safe throughout your treatment journey.

During your initial consultation at Bodyline, one of our experienced clinicians will conduct a comprehensive assessment that includes reviewing your medical history, current medications, previous weight loss attempts, family history of diabetes and cardiovascular disease, and any relevant health conditions. We'll discuss your weight loss goals, lifestyle factors, and any concerns you may have about injectable medications. This thorough evaluation allows us to create a personalised treatment plan that's tailored to your unique needs and circumstances rather than taking a one-size-fits-all approach.

Certain medical conditions may make Trulicity unsuitable or require special precautions. For example, people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 should not use Trulicity due to potential risks. Those with a history of pancreatitis, severe gastrointestinal disease, or diabetic retinopathy should be carefully evaluated before starting treatment. Pregnant or breastfeeding women should not use Trulicity, and women of childbearing age should use effective contraception during treatment. Our clinicians will carefully review all contraindications and precautions to ensure your safety.

Once it has been determined that Trulicity® is the right treatment option for you, we can provide initial consultations, prescriptions, and monthly reviews, as well as fortnightly support calls to ensure you are being looked after throughout your Trulicity® journey. This comprehensive support structure sets Bodyline apart from online-only services or clinics that simply dispense medication without ongoing clinical oversight. We believe that successful weight loss requires a partnership between patient and healthcare provider, with regular communication, monitoring, and adjustments to your treatment plan as needed.

Your treatment will typically begin with a lower starting dose of Trulicity to allow your body to adjust to the medication and minimise gastrointestinal side effects. The dose may be gradually increased over several weeks or months based on your response, tolerability, and treatment goals. Our clinical team will guide you through this dose escalation process, advising you on what to expect at each stage and how to manage any side effects that may occur. Common side effects such as nausea, reduced appetite, and changes in bowel habits are usually temporary and diminish as your body adapts to the medication.

Throughout your treatment, we'll monitor various health markers including weight, blood pressure, blood sugar levels (if you have diabetes), and overall wellbeing. Regular weigh-ins and progress reviews help keep you motivated and allow us to identify and address any challenges early. We'll also provide nutritional guidance to help you make the most of your reduced appetite, ensuring you're consuming adequate protein, vitamins, and minerals despite eating less overall. Physical activity recommendations will be tailored to your current fitness level and gradually progressed as your weight decreases and your capabilities improve.

This ongoing support will ensure you are supported and happy as you begin to see results and reduction in diabetes symptoms if applicable. Many patients notice improvements in blood sugar control within the first few weeks of treatment, with progressive weight loss occurring over several months. The rate of weight loss varies between individuals, but most people can expect to lose a meaningful amount of weight—typically 5-10% or more of their starting body weight—when Trulicity is combined with appropriate lifestyle modifications. For someone starting at 100kg, this could represent 5-10kg of weight loss or more, which can have profound effects on health markers, mobility, and quality of life.

It's important to understand that Trulicity is not a quick fix or temporary solution—it's a long-term treatment that works best when used consistently over an extended period. Many people will need to continue the medication for months or even years to maintain their weight loss and health improvements. Our team at Bodyline will work with you to develop a sustainable long-term strategy that may include ongoing medication, lifestyle maintenance, and periodic reviews to ensure continued success. We're committed to supporting you not just through the initial weight loss phase but also through the equally important maintenance phase where keeping weight off is the goal.

The decision to start any weight loss medication is significant and should be made collaboratively with qualified healthcare professionals who understand your individual circumstances. At Bodyline, we pride ourselves on providing personalised, evidence-based care delivered by experienced clinicians who specialise in weight management and metabolic health. We've helped thousands of patients across the UK achieve their weight loss goals through our comprehensive treatment programmes, and we're here to support you every step of the way.

Trulicity is a promising medical weight loss treatment that has the potential to improve the lives of millions of people struggling with obesity and type 2 diabetes. The medication represents a significant advancement in our ability to help people achieve meaningful, sustainable weight loss whilst simultaneously improving metabolic health and reducing cardiovascular risk. For many patients who have struggled for years with traditional diet and exercise approaches, Trulicity provides the biological support needed to finally break through barriers and achieve lasting results.

If you are struggling with weight loss and want to learn more about Trulicity® and whether it might be appropriate for your situation, call Bodyline Medical Wellness Clinics today at 0800 995 6036 or fill in our online contact form for a call back from one of our friendly team members. Our team of experts can answer any questions you may have and help you determine if Trulicity is the right treatment option for you based on your individual medical history, treatment goals, and personal circumstances.

We understand that taking the first step towards medical weight loss treatment can feel daunting, and you may have concerns about injectable medications, potential side effects, cost, or whether treatment will actually work for you. These concerns are completely normal, and our team is here to address them with honest, evidence-based information delivered in a supportive, non-judgmental environment. We offer an initial, no-obligation consultation where you can discuss your situation with one of our clinicians, ask questions, and learn about all available treatment options without any obligation to proceed.

Bodyline Clinic has been at the forefront of medical weight loss treatment in the UK for over 18 years, supporting more than 100,000 patients through their weight loss journeys. We're proud to be CQC-regulated, ensuring that our services meet the highest standards of safety, effectiveness, and patient care. Our clinics are conveniently located across the Northwest of England, including Birkenhead, Liverpool, Manchester, St Helens, Stockport, Stoke-on-Trent, and Warrington, and we also offer online consultations for patients throughout the UK who cannot easily access our physical locations.

Don't let another year go by struggling with your weight and the health complications that come with it. Whether Trulicity, another GLP-1 medication like Wegovy or Mounjaro, or a different treatment approach proves to be the right choice for you, the important thing is taking that first step towards better health. Contact Bodyline today to begin your journey towards sustainable weight loss, improved metabolic health, and a better quality of life. Our experienced team is ready to support you with the expertise, compassion, and ongoing care you deserve.